PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 1,377
- Locations
- 1
- Primary Endpoint
- PrEP Prescriptions
Study Overview
Brief Summary
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patient of UAB GYN clinic
Exclusion Criteria
- •Not a patient of UAB GYN clinic
Arms & Interventions
Sexual Health-PRO
Patients seen during routine GYN clinic visit.
Intervention: PrEP acronym (pre-exposure prophylaxis) (Behavioral)
Post visit (fidelity) survey
Patients who completed the survey outside of clinic visit
Intervention: PrEP acronym (pre-exposure prophylaxis) (Behavioral)
Outcomes
Primary Outcomes
PrEP Prescriptions
Time Frame: 8 months
Number of participants receiving a new PrEP prescription during the recruitment period
Secondary Outcomes
No secondary outcomes reported
Investigators
Michael J Mugavero, MD
Professor
University of Alabama at Birmingham